Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept

NCT01379508 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

241

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: telbivudine
DRUG: tenofovir disoproxil fumarate

Sponsor

Novartis Pharmaceuticals